A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists

NCT06322641 · clinicaltrials.gov ↗

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerotic Cardiovascular Disease (ASCVD)
Chronic Kidney Disease (CKD)
Systemic Inflammation

Interventions

OTHER: No treatment given

Sponsor

Novo Nordisk A/S